AnaptysBio, Inc. ANAB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $232.39M-0.9% | $234.6M+38.4% | $169.47M+37.6% | $123.16M+10.1% | $111.87M+22.6% | ||
| $128.78M-5.3% | $135.97M-11.1% | $153M-6.6% | $163.81M-2.5% | $167.98M+2.5% | ||
| $62.81M+23.8% | $50.74M+12.4% | $45.14M-0.8% | $45.5M+3.0% | $44.18M+4.2% | ||
| $191.59M+2.6% | $186.71M-5.8% | $198.14M-5.3% | $209.3M-1.3% | $212.16M+2.9% | ||
| $40.8M-14.8% | $47.9M+267% | -$28.68M+66.7% | -$86.14M+14.1% | -$100.29M+12.8% | ||
| 17.6%-2.9pp | 20.4%+37.3pp | -16.9%+53.0pp | -69.9%+19.7pp | -89.6%+36.3pp | ||
| -$67.43M-10.6% | -$60.96M-9.1% | -$55.88M-20.5% | -$46.38M-15.1% | -$40.29M-33.1% | ||
| —— | —— | -$84.55M+36.2% | -$132.52M+5.7% | -$140.58M+3.2% | ||
| $160K-2.4% | $164K— | —— | —— | —— | ||
| —— | —— | -$84.63M+36.2% | -$132.59M+5.7% | -$140.62M+3.2% | ||
| —— | —— | -$2.76+37.6% | -$4.42+7.7% | -$4.79+7.0% | ||
| $41.34M-14.7% | $48.46M+272% | -$28.1M+67.2% | -$85.56M+14.2% | -$99.7M+12.8% | ||
| 17.8%-2.9pp | 20.7%+37.2pp | -16.6%+52.9pp | -69.5%+19.7pp | -89.1%+36.1pp | ||
| $40.8M-14.8% | $47.9M+267% | -$28.68M+66.7% | -$86.14M+14.1% | -$100.29M+12.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AnaptysBio, Inc.'s income statement data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.